A carregar...
Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies
A discussion of rational endpoints in clinical trials seeking regulatory approval for new anti-neoplastic agents involving the three major gynecologic malignancies, cancers of the ovary, cervix, and endometrial, is particularly interesting as (in the opinion of this commentator) the conclusion will...
Na minha lista:
| Publicado no: | Womens Health (Lond) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5373277/ https://ncbi.nlm.nih.gov/pubmed/27638892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1745505716655555 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|